Likewise, effective treatment of early heart failure with routine use of beta blockers, angiotensin converting enzyme (ACE) inhibitors, anti-platelet medications and lipid lowering agents after a myocardial infarction has dramatically reduced the incidence of further myocardial damage and subsequent breathlessness as a cause of chronic cardiac-related breathlessness. This evidence concerns the gene ACE and myocardial infarction.